← Leaderboards
Robert D. Burk
Icahn School Of Medicine At Mount Sinai
$24,637,183
Attributed
$45,515,251
Total exposure
17
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,515,251 · 17
By mechanism
R01$31,545,634 · 9
U01$11,445,615 · 2
R21$1,266,933 · 3
R56$1,257,069 · 2
M01$0 · 1
Top collaborators
- Nicolas Schlecht23 shared
- Angela Diaz15 shared
- Howard D Strickler11 shared
- Robert C Kaplan9 shared
- Jorge R Kizer6 shared
- Robin Knight6 shared
- Patricia Diaz4 shared
- Jennifer Cohen Price3 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Nicolas Schlecht$8,465,862
- Angela Diaz$9,604,054
Others in their field
Top investigators on “Human Papillomavirus”
- Ronald T Mitsuyasu · University Of California Los Angeles$106,431,894
- Leonard Freedman · Leidos Biomedical Research, Inc.$53,948,093
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$50,130,116
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- David Heimbrook · Leidos Biomedical Research, Inc.$33,306,253
- Paul F Lambert · University Of Wisconsin Madison$31,091,618
Research focus
Human PapillomavirusCohortSamplingRisk FactorsWomanInfectionDetectionHuman Papillomavirus 16Human Papilloma Virus InfectionCohort StudiesDesignSpecimenMalignant Neoplasm Of Cervix UteriNatural HistoryHigh RiskFollow-UpCervicalScreeningHpv-High RiskFutureVaccinesReportingOncogenicIncidence
Grant awards (79)
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,215,107
R01 · FY2025 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$810,013
R01 · FY2025 · DE · contact PI
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection$705,769
R01 · FY2025 · HL
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults$695,447
R01 · FY2025 · DK
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,231,345
R01 · FY2024 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$801,143
R01 · FY2024 · DE · contact PI
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection$700,116
R01 · FY2024 · HL
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults$645,272
R01 · FY2024 · DK
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$516,029
U01 · FY2024 · CA · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,256,429
R01 · FY2023 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$820,582
R01 · FY2023 · DE · contact PI
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults$772,730
R01 · FY2023 · DK
Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection$757,962
R01 · FY2023 · HL
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$571,572
U01 · FY2023 · CA · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$924,957
R01 · FY2022 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence$858,030
R01 · FY2022 · DE · contact PI
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$655,774
R01 · FY2022 · CA
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$571,574
U01 · FY2022 · CA · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$921,365
R01 · FY2021 · AI
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$655,774
R01 · FY2021 · CA
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$583,239
U01 · FY2021 · CA · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$917,545
R01 · FY2020 · AI
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$752,099
R01 · FY2020 · MD
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$648,844
R01 · FY2020 · CA
Investigations Into The Molecular Pathogenesis Of Cervical Glandular Neoplasias$559,479
U01 · FY2020 · CA · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$914,592
R01 · FY2019 · AI
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$762,057
R01 · FY2019 · MD
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$628,673
R01 · FY2019 · CA
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$439,524
R01 · FY2019 · MD
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$927,425
R01 · FY2018 · AI
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$768,196
R01 · FY2018 · MD
Impact of HIV, oral microbiome and mycobiome on oral HPV$422,533
R56 · FY2018 · DE
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$349,777
R01 · FY2018 · CA
Next Generation of HPV and Cervical Cancer Research in HIV+ Women$320,518
R01 · FY2018 · CA
Persistent HPV Infection in Women at Risk for Cervix Cancer$309,572
U01 · FY2018 · CA · contact PI
Persistent HPV Infection in Women at Risk for Cervix Cancer$272,019
U01 · FY2018 · CA · contact PI
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$764,306
R01 · FY2017 · MD
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$762,612
R01 · FY2017 · AI
Persistent HPV Infection in Women at Risk for Cervix Cancer$581,591
U01 · FY2017 · CA · contact PI
Beta & Gamma Oral HPV infection in HIV positive individuals$133,869
R21 · FY2017 · DE
Beta & Gamma Oral HPV infection in HIV positive individuals$74,881
R21 · FY2017 · DE
Epidemiology of the gut microbiome, prediabetes and diabetes in Latinos$829,412
R01 · FY2016 · MD
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$780,197
R01 · FY2016 · AI
Persistent HPV Infection in Women at Risk for Cervix Cancer$581,591
U01 · FY2016 · CA · contact PI
Beta & Gamma Oral HPV infection in HIV positive individuals$250,500
R21 · FY2016 · DE
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,253,871
R01 · FY2015 · AI
Persistent HPV Infection in Women at Risk for Cervix Cancer$509,450
U01 · FY2015 · CA · contact PI
Persistent HPV Infection in Women at Risk for Cervix Cancer$72,141
U01 · FY2015 · CA · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$1,028,088
R01 · FY2014 · AI
Persistent HPV Infection in Women at Risk for Cervix Cancer$581,591
U01 · FY2014 · CA · contact PI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$686,990
R01 · FY2013 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$39,971
R01 · FY2013 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls$834,536
R56 · FY2012 · AI
Persistent HPV in Women at Risk for Cervix Cancer$567,757
U01 · FY2012 · CA · contact PI
Prospective Oral HPV and Risk of Head and Neck Cancers$181,341
R21 · FY2012 · CA · contact PI
Persistent HPV in Women at Risk for Cervix Cancer$566,238
U01 · FY2011 · CA · contact PI
Prospective Oral HPV and Risk of Head and Neck Cancers$175,934
R21 · FY2011 · CA · contact PI
Persistent HPV in Women at Risk for Cervix Cancer$596,586
U01 · FY2010 · CA · contact PI
Development of a Primate Model for Genital Papillomavirus Infection$231,123
R21 · FY2010 · AI · contact PI
Persistent HPV in Women at Risk for Cervix Cancer$590,661
U01 · FY2009 · CA · contact PI
Development of a Primate Model for Genital Papillomavirus Infection$219,285
R21 · FY2009 · AI · contact PI
Persistent HPV in Women at Risk for Cervix Cancer$580,919
U01 · FY2008 · CA · contact PI
PERSISTENT HUMAN PAPILLOMAVIRUS IN WOMEN AT RISK FOR CERVIX CANCER$570,360
U01 · FY2007 · CA · contact PI
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCER$574,278
U01 · FY2006 · CA · contact PI
Functional Analysis of the VHL Tumor Suppressor Gene$289,082
R01 · FY2006 · CA · contact PI
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCER$575,056
U01 · FY2005 · CA
Functional Analysis of the VHL Tumor Suppressor Gene$296,086
R01 · FY2005 · CA
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCER$562,394
U01 · FY2004 · CA
Functional Analysis of the VHL Tumor Suppressor Gene$296,131
R01 · FY2004 · CA
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCER$551,518
U01 · FY2003 · CA
Functional Analysis of the VHL Tumor Suppressor Gene$296,175
R01 · FY2003 · CA
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCER$497,791
R01 · FY2002 · CA
Functional Analysis of the VHL Tumor Suppressor Gene$296,584
R01 · FY2002 · CA
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCER$484,048
R01 · FY2001 · CA
NATURAL HISTORY OF ACUTE HPV INFECTION$312,823
R01 · FY2001 · AI
INVESTIGATION OF HEREDITARY PROSTATE CANCER$0
M01 · FY2001 · RR
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCER$470,709
R01 · FY2000 · CA
NATURAL HISTORY OF ACUTE HPV INFECTION$303,693
R01 · FY2000 · AI
INVESTIGATION OF HEREDITARY PROSTATE CANCER$0
M01 · FY2000 · RR